Structure

Physi-Chem Properties

Molecular Weight:  298.16
Volume:  327.983
LogP:  5.862
LogD:  4.381
LogS:  -4.882
# Rotatable Bonds:  6
TPSA:  50.44
# H-Bond Aceptor:  3
# H-Bond Donor:  1
# Rings:  2
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.583
Synthetic Accessibility Score:  3.149
Fsp3:  0.316
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.832
MDCK Permeability:  2.1042795196990483e-05
Pgp-inhibitor:  0.185
Pgp-substrate:  0.008
Human Intestinal Absorption (HIA):  0.009
20% Bioavailability (F20%):  0.76
30% Bioavailability (F30%):  0.99

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.036
Plasma Protein Binding (PPB):  97.61363220214844%
Volume Distribution (VD):  3.882
Pgp-substrate:  5.287134170532227%

ADMET: Metabolism

CYP1A2-inhibitor:  0.975
CYP1A2-substrate:  0.421
CYP2C19-inhibitor:  0.942
CYP2C19-substrate:  0.2
CYP2C9-inhibitor:  0.813
CYP2C9-substrate:  0.947
CYP2D6-inhibitor:  0.607
CYP2D6-substrate:  0.864
CYP3A4-inhibitor:  0.496
CYP3A4-substrate:  0.118

ADMET: Excretion

Clearance (CL):  5.629
Half-life (T1/2):  0.136

ADMET: Toxicity

hERG Blockers:  0.011
Human Hepatotoxicity (H-HT):  0.792
Drug-inuced Liver Injury (DILI):  0.733
AMES Toxicity:  0.098
Rat Oral Acute Toxicity:  0.049
Maximum Recommended Daily Dose:  0.925
Skin Sensitization:  0.884
Carcinogencity:  0.638
Eye Corrosion:  0.082
Eye Irritation:  0.939
Respiratory Toxicity:  0.774

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC290927

Natural Product ID:  NPC290927
Common Name*:   2-(2',3-Epoxy-1',3'-Heptadienyl)-6-Hydroxy-5-(3-Methyl-2-Butenyl)Benzaldehyde
IUPAC Name:   5-hydroxy-6-(3-methylbut-2-enyl)-2-[(E)-pent-1-enyl]-1-benzofuran-4-carbaldehyde
Synonyms:  
Standard InCHIKey:  SBYYFNVKZGJIPR-VOTSOKGWSA-N
Standard InCHI:  InChI=1S/C19H22O3/c1-4-5-6-7-15-11-16-17(12-20)19(21)14(9-8-13(2)3)10-18(16)22-15/h6-8,10-12,21H,4-5,9H2,1-3H3/b7-6+
SMILES:  CCC/C=C/c1oc2c(c1)c(C=O)c(c(c2)CC=C(C)C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL462797
PubChem CID:   44559107
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000301] Benzofurans

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota n.a. n.a. n.a. PMID[12357398]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota n.a. n.a. n.a. PMID[12483566]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota n.a. n.a. n.a. PMID[15497948]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota n.a. n.a. n.a. PMID[15921417]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota n.a. n.a. n.a. PMID[16209910]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota n.a. n.a. n.a. PMID[16499339]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota n.a. n.a. n.a. PMID[16872138]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota n.a. n.a. n.a. PMID[16904330]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota n.a. n.a. n.a. PMID[17125234]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota n.a. n.a. n.a. PMID[17827664]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota n.a. n.a. n.a. PMID[19246197]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota Ginkgo biloba n.a. n.a. PMID[19246197]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota n.a. n.a. n.a. PMID[19427327]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota n.a. n.a. n.a. PMID[20225834]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota n.a. n.a. n.a. PMID[20814854]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota n.a. mycelium n.a. PMID[21548578]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota n.a. n.a. n.a. PMID[21548578]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota isolated from the leaves of Viguiera robusta n.a. n.a. PMID[21548578]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota n.a. n.a. n.a. PMID[21640594]
NPO30824 Eurotium repens Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[21667972]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota n.a. n.a. n.a. PMID[21854043]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota n.a. n.a. n.a. PMID[22112725]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota n.a. n.a. n.a. PMID[22593034]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota n.a. n.a. n.a. PMID[23072467]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota n.a. Xichang of Sichuan Province, China n.a. PMID[26125976]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota n.a. n.a. n.a. PMID[26343828]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota n.a. n.a. n.a. PMID[5066072]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota n.a. n.a. n.a. PMID[7116505]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota n.a. n.a. n.a. Database[CiteXplore Id]
NPO24171 Chaetomium globosum Species Chaetomiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT271 Individual Protein Delta opioid receptor Homo sapiens Activity < 40.0 % PMID[574308]
NPT272 Individual Protein Kappa opioid receptor Homo sapiens Activity < 40.0 % PMID[574308]
NPT145 Individual Protein Mu opioid receptor Homo sapiens Activity < 40.0 % PMID[574308]
NPT232 Individual Protein Cannabinoid CB1 receptor Homo sapiens Activity < 40.0 % PMID[574308]
NPT1287 Individual Protein Cannabinoid CB2 receptor Homo sapiens Activity < 40.0 % PMID[574308]
NPT1 Others Radical scavenging activity IC50 = 88.0 ug.mL-1 PMID[574307]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 2.8 ug.mL-1 PMID[574309]
NPT1666 Organism Plasmodium falciparum D6 Plasmodium falciparum D6 IC50 = 3.0 ug.mL-1 PMID[574309]
NPT633 Organism Leishmania donovani Leishmania donovani IC50 = 6.2 ug.mL-1 PMID[574309]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus IC50 = 5.4 ug.mL-1 PMID[574309]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus IC50 = 7.75 ug.mL-1 PMID[574309]
NPT85 Organism Filobasidiella neoformans Cryptococcus neoformans IC50 = 5.31 ug.mL-1 PMID[574309]
NPT554 Organism Candida glabrata Candida glabrata IC50 = 1.13 ug.mL-1 PMID[574309]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC290927 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9226 High Similarity NPC24761
0.8861 High Similarity NPC269117
0.8839 High Similarity NPC84721
0.879 High Similarity NPC212967
0.879 High Similarity NPC246647
0.879 High Similarity NPC164110
0.879 High Similarity NPC96342
0.8726 High Similarity NPC180924
0.8726 High Similarity NPC221992
0.871 High Similarity NPC145830
0.8701 High Similarity NPC226578
0.8699 High Similarity NPC265793
0.8675 High Similarity NPC117674
0.8662 High Similarity NPC148938
0.8627 High Similarity NPC281398
0.8618 High Similarity NPC93241
0.8618 High Similarity NPC27798
0.8609 High Similarity NPC329493
0.8608 High Similarity NPC247677
0.8608 High Similarity NPC160015
0.8599 High Similarity NPC179170
0.8599 High Similarity NPC235333
0.859 High Similarity NPC116604
0.8581 High Similarity NPC278832
0.8581 High Similarity NPC64157
0.8571 High Similarity NPC252208
0.8553 High Similarity NPC473282
0.8553 High Similarity NPC260902
0.8553 High Similarity NPC104380
0.8553 High Similarity NPC217602
0.8553 High Similarity NPC317900
0.8553 High Similarity NPC299094
0.8553 High Similarity NPC10051
0.8553 High Similarity NPC476404
0.8553 High Similarity NPC296957
0.8553 High Similarity NPC294300
0.8553 High Similarity NPC44199
0.8544 High Similarity NPC297531
0.8544 High Similarity NPC213936
0.8543 High Similarity NPC124365
0.8535 High Similarity NPC253872
0.8535 High Similarity NPC263676
0.8535 High Similarity NPC207624
0.8526 High Similarity NPC13282
0.8523 High Similarity NPC130976
0.8506 High Similarity NPC300540
0.8506 High Similarity NPC308799
0.85 High Similarity NPC472877
0.85 High Similarity NPC476349
0.85 High Similarity NPC477692
0.85 High Similarity NPC476350
0.8497 Intermediate Similarity NPC89664
0.8497 Intermediate Similarity NPC274085
0.8497 Intermediate Similarity NPC469642
0.8481 Intermediate Similarity NPC158261
0.8481 Intermediate Similarity NPC42458
0.8481 Intermediate Similarity NPC208806
0.8471 Intermediate Similarity NPC115324
0.8471 Intermediate Similarity NPC58668
0.8471 Intermediate Similarity NPC106372
0.8471 Intermediate Similarity NPC170169
0.8471 Intermediate Similarity NPC193976
0.8471 Intermediate Similarity NPC23668
0.8467 Intermediate Similarity NPC98395
0.8466 Intermediate Similarity NPC136641
0.8457 Intermediate Similarity NPC193998
0.8452 Intermediate Similarity NPC113428
0.8452 Intermediate Similarity NPC61284
0.8447 Intermediate Similarity NPC472781
0.8447 Intermediate Similarity NPC472782
0.8447 Intermediate Similarity NPC143050
0.8438 Intermediate Similarity NPC268360
0.8431 Intermediate Similarity NPC158871
0.8428 Intermediate Similarity NPC233776
0.8428 Intermediate Similarity NPC198490
0.8418 Intermediate Similarity NPC40356
0.8418 Intermediate Similarity NPC67654
0.8418 Intermediate Similarity NPC154683
0.8418 Intermediate Similarity NPC142308
0.8415 Intermediate Similarity NPC191012
0.8411 Intermediate Similarity NPC1268
0.8408 Intermediate Similarity NPC230713
0.8408 Intermediate Similarity NPC167576
0.8408 Intermediate Similarity NPC144010
0.8408 Intermediate Similarity NPC472406
0.8408 Intermediate Similarity NPC78335
0.8397 Intermediate Similarity NPC5537
0.8395 Intermediate Similarity NPC304387
0.8395 Intermediate Similarity NPC472780
0.8395 Intermediate Similarity NPC472783
0.8393 Intermediate Similarity NPC295914
0.8389 Intermediate Similarity NPC281513
0.8389 Intermediate Similarity NPC22222
0.8385 Intermediate Similarity NPC472299
0.8377 Intermediate Similarity NPC477409
0.8377 Intermediate Similarity NPC469385
0.8365 Intermediate Similarity NPC1477
0.8365 Intermediate Similarity NPC477691
0.8365 Intermediate Similarity NPC213608
0.8365 Intermediate Similarity NPC135522
0.8365 Intermediate Similarity NPC183874
0.8365 Intermediate Similarity NPC88958
0.8364 Intermediate Similarity NPC186392
0.8354 Intermediate Similarity NPC156244
0.8354 Intermediate Similarity NPC291110
0.8353 Intermediate Similarity NPC475996
0.8344 Intermediate Similarity NPC62735
0.8344 Intermediate Similarity NPC37226
0.8344 Intermediate Similarity NPC226644
0.8344 Intermediate Similarity NPC178202
0.8344 Intermediate Similarity NPC233707
0.8333 Intermediate Similarity NPC198427
0.8333 Intermediate Similarity NPC313368
0.8323 Intermediate Similarity NPC98926
0.8322 Intermediate Similarity NPC209858
0.8313 Intermediate Similarity NPC99199
0.8304 Intermediate Similarity NPC8927
0.8304 Intermediate Similarity NPC228209
0.8303 Intermediate Similarity NPC277480
0.8303 Intermediate Similarity NPC53640
0.8302 Intermediate Similarity NPC24232
0.8302 Intermediate Similarity NPC477690
0.8302 Intermediate Similarity NPC38361
0.8302 Intermediate Similarity NPC130015
0.8302 Intermediate Similarity NPC10429
0.8302 Intermediate Similarity NPC5871
0.8301 Intermediate Similarity NPC28337
0.8293 Intermediate Similarity NPC101769
0.8293 Intermediate Similarity NPC100849
0.8291 Intermediate Similarity NPC294646
0.8291 Intermediate Similarity NPC227122
0.828 Intermediate Similarity NPC135325
0.8274 Intermediate Similarity NPC277510
0.8272 Intermediate Similarity NPC228501
0.8269 Intermediate Similarity NPC190572
0.8269 Intermediate Similarity NPC300267
0.8269 Intermediate Similarity NPC51641
0.8253 Intermediate Similarity NPC472660
0.8253 Intermediate Similarity NPC473945
0.8253 Intermediate Similarity NPC247973
0.8253 Intermediate Similarity NPC95715
0.825 Intermediate Similarity NPC472462
0.825 Intermediate Similarity NPC169990
0.825 Intermediate Similarity NPC122365
0.825 Intermediate Similarity NPC72370
0.825 Intermediate Similarity NPC214632
0.825 Intermediate Similarity NPC210942
0.8247 Intermediate Similarity NPC69755
0.8242 Intermediate Similarity NPC37183
0.8242 Intermediate Similarity NPC38914
0.8242 Intermediate Similarity NPC472784
0.8239 Intermediate Similarity NPC72958
0.8239 Intermediate Similarity NPC258249
0.8239 Intermediate Similarity NPC471613
0.8239 Intermediate Similarity NPC474417
0.8239 Intermediate Similarity NPC149526
0.8239 Intermediate Similarity NPC232645
0.8235 Intermediate Similarity NPC23553
0.8235 Intermediate Similarity NPC221820
0.8235 Intermediate Similarity NPC77179
0.8229 Intermediate Similarity NPC60848
0.8228 Intermediate Similarity NPC296030
0.8228 Intermediate Similarity NPC65589
0.8228 Intermediate Similarity NPC288036
0.8228 Intermediate Similarity NPC39929
0.8228 Intermediate Similarity NPC97029
0.8228 Intermediate Similarity NPC266499
0.8228 Intermediate Similarity NPC97028
0.8228 Intermediate Similarity NPC100985
0.8228 Intermediate Similarity NPC158338
0.8221 Intermediate Similarity NPC476506
0.8221 Intermediate Similarity NPC470810
0.8221 Intermediate Similarity NPC284495
0.8217 Intermediate Similarity NPC17816
0.8217 Intermediate Similarity NPC12148
0.8217 Intermediate Similarity NPC478018
0.8217 Intermediate Similarity NPC71055
0.8217 Intermediate Similarity NPC150215
0.8217 Intermediate Similarity NPC137296
0.8217 Intermediate Similarity NPC130581
0.8214 Intermediate Similarity NPC307286
0.8212 Intermediate Similarity NPC141934
0.8212 Intermediate Similarity NPC163029
0.821 Intermediate Similarity NPC269495
0.821 Intermediate Similarity NPC270044
0.821 Intermediate Similarity NPC201127
0.821 Intermediate Similarity NPC263483
0.821 Intermediate Similarity NPC196448
0.821 Intermediate Similarity NPC65504
0.821 Intermediate Similarity NPC123153
0.8199 Intermediate Similarity NPC89625
0.8199 Intermediate Similarity NPC149618
0.8194 Intermediate Similarity NPC476473
0.8194 Intermediate Similarity NPC53016
0.8188 Intermediate Similarity NPC118253
0.8187 Intermediate Similarity NPC271681
0.8187 Intermediate Similarity NPC474843
0.8187 Intermediate Similarity NPC87708
0.8187 Intermediate Similarity NPC281272
0.8182 Intermediate Similarity NPC308156

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC290927 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8462 Intermediate Similarity NPD3226 Approved
0.8224 Intermediate Similarity NPD2344 Approved
0.8105 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.8089 Intermediate Similarity NPD2532 Approved
0.8089 Intermediate Similarity NPD2533 Approved
0.8089 Intermediate Similarity NPD2534 Approved
0.8061 Intermediate Similarity NPD1247 Approved
0.8013 Intermediate Similarity NPD2309 Approved
0.7987 Intermediate Similarity NPD1471 Phase 3
0.7987 Intermediate Similarity NPD2346 Discontinued
0.7875 Intermediate Similarity NPD920 Approved
0.7862 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7849 Intermediate Similarity NPD6559 Discontinued
0.7844 Intermediate Similarity NPD6959 Discontinued
0.7805 Intermediate Similarity NPD7819 Suspended
0.7771 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.775 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7736 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7719 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD6232 Discontinued
0.7692 Intermediate Similarity NPD2935 Discontinued
0.7679 Intermediate Similarity NPD5494 Approved
0.7665 Intermediate Similarity NPD3749 Approved
0.7661 Intermediate Similarity NPD7473 Discontinued
0.7651 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7627 Intermediate Similarity NPD8434 Phase 2
0.7613 Intermediate Similarity NPD1607 Approved
0.7605 Intermediate Similarity NPD3882 Suspended
0.759 Intermediate Similarity NPD2801 Approved
0.7582 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.758 Intermediate Similarity NPD1551 Phase 2
0.7576 Intermediate Similarity NPD7411 Suspended
0.7572 Intermediate Similarity NPD5844 Phase 1
0.7547 Intermediate Similarity NPD1243 Approved
0.7547 Intermediate Similarity NPD2800 Approved
0.7533 Intermediate Similarity NPD6696 Suspended
0.7516 Intermediate Similarity NPD2799 Discontinued
0.7515 Intermediate Similarity NPD919 Approved
0.75 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7484 Intermediate Similarity NPD1240 Approved
0.7484 Intermediate Similarity NPD1549 Phase 2
0.7483 Intermediate Similarity NPD1470 Approved
0.7468 Intermediate Similarity NPD2796 Approved
0.7468 Intermediate Similarity NPD2313 Discontinued
0.7459 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7444 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.744 Intermediate Similarity NPD5616 Clinical (unspecified phase)
0.744 Intermediate Similarity NPD2296 Approved
0.7425 Intermediate Similarity NPD1934 Approved
0.7423 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7421 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7421 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.741 Intermediate Similarity NPD4380 Phase 2
0.7405 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7405 Intermediate Similarity NPD1510 Phase 2
0.7391 Intermediate Similarity NPD4628 Phase 3
0.7384 Intermediate Similarity NPD5711 Approved
0.7384 Intermediate Similarity NPD5710 Approved
0.7381 Intermediate Similarity NPD5760 Phase 2
0.7381 Intermediate Similarity NPD5761 Phase 2
0.7375 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.736 Intermediate Similarity NPD8313 Approved
0.736 Intermediate Similarity NPD8312 Approved
0.7353 Intermediate Similarity NPD7075 Discontinued
0.7349 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7341 Intermediate Similarity NPD3926 Phase 2
0.7333 Intermediate Similarity NPD1201 Approved
0.7321 Intermediate Similarity NPD6279 Approved
0.7321 Intermediate Similarity NPD6280 Approved
0.7314 Intermediate Similarity NPD7177 Discontinued
0.7314 Intermediate Similarity NPD3818 Discontinued
0.7305 Intermediate Similarity NPD6599 Discontinued
0.7294 Intermediate Similarity NPD7768 Phase 2
0.7278 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7256 Intermediate Similarity NPD1511 Approved
0.725 Intermediate Similarity NPD6100 Approved
0.725 Intermediate Similarity NPD6099 Approved
0.7235 Intermediate Similarity NPD5402 Approved
0.7219 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7209 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD2798 Approved
0.7184 Intermediate Similarity NPD6808 Phase 2
0.7181 Intermediate Similarity NPD6777 Approved
0.7181 Intermediate Similarity NPD6781 Approved
0.7181 Intermediate Similarity NPD6778 Approved
0.7181 Intermediate Similarity NPD6782 Approved
0.7181 Intermediate Similarity NPD6776 Approved
0.7181 Intermediate Similarity NPD6780 Approved
0.7181 Intermediate Similarity NPD6779 Approved
0.7179 Intermediate Similarity NPD4625 Phase 3
0.7178 Intermediate Similarity NPD3750 Approved
0.7178 Intermediate Similarity NPD7003 Approved
0.7178 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7171 Intermediate Similarity NPD1608 Approved
0.7169 Intermediate Similarity NPD1512 Approved
0.7162 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD6799 Approved
0.7152 Intermediate Similarity NPD7390 Discontinued
0.7151 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD411 Approved
0.7133 Intermediate Similarity NPD1651 Approved
0.7118 Intermediate Similarity NPD6844 Discontinued
0.7118 Intermediate Similarity NPD6801 Discontinued
0.7107 Intermediate Similarity NPD447 Suspended
0.7102 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7102 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7102 Intermediate Similarity NPD6166 Phase 2
0.7095 Intermediate Similarity NPD1252 Clinical (unspecified phase)
0.7095 Intermediate Similarity NPD5953 Discontinued
0.7086 Intermediate Similarity NPD1778 Approved
0.7086 Intermediate Similarity NPD4626 Approved
0.7078 Intermediate Similarity NPD1283 Approved
0.7073 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7068 Intermediate Similarity NPD7697 Approved
0.7068 Intermediate Similarity NPD7435 Discontinued
0.7068 Intermediate Similarity NPD7696 Phase 3
0.7068 Intermediate Similarity NPD7698 Approved
0.7066 Intermediate Similarity NPD6273 Approved
0.7059 Intermediate Similarity NPD9717 Approved
0.7059 Intermediate Similarity NPD3972 Approved
0.7051 Intermediate Similarity NPD2861 Phase 2
0.7051 Intermediate Similarity NPD9494 Approved
0.7049 Intermediate Similarity NPD8150 Discontinued
0.7037 Intermediate Similarity NPD5408 Approved
0.7037 Intermediate Similarity NPD5405 Approved
0.7037 Intermediate Similarity NPD5404 Approved
0.7037 Intermediate Similarity NPD5406 Approved
0.7035 Intermediate Similarity NPD3817 Phase 2
0.7032 Intermediate Similarity NPD1203 Approved
0.7031 Intermediate Similarity NPD7870 Phase 2
0.7031 Intermediate Similarity NPD7871 Phase 2
0.7025 Intermediate Similarity NPD3268 Approved
0.7025 Intermediate Similarity NPD3764 Approved
0.7022 Intermediate Similarity NPD2163 Approved
0.7022 Intermediate Similarity NPD3751 Discontinued
0.702 Intermediate Similarity NPD5691 Approved
0.7017 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD4575 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD6832 Phase 2
0.7 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.6994 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6994 Remote Similarity NPD6002 Phase 3
0.6994 Remote Similarity NPD6005 Phase 3
0.6994 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6994 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6994 Remote Similarity NPD6004 Phase 3
0.6993 Remote Similarity NPD1611 Approved
0.6989 Remote Similarity NPD7229 Phase 3
0.6983 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6983 Remote Similarity NPD7286 Phase 2
0.6975 Remote Similarity NPD7033 Discontinued
0.6974 Remote Similarity NPD17 Approved
0.6968 Remote Similarity NPD1876 Approved
0.6961 Remote Similarity NPD3658 Clinical (unspecified phase)
0.6954 Remote Similarity NPD9545 Approved
0.6944 Remote Similarity NPD7074 Phase 3
0.6944 Remote Similarity NPD1729 Discontinued
0.6941 Remote Similarity NPD7458 Discontinued
0.6937 Remote Similarity NPD2979 Phase 3
0.6928 Remote Similarity NPD3496 Discontinued
0.6923 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6923 Remote Similarity NPD7701 Phase 2
0.6915 Remote Similarity NPD6534 Approved
0.6915 Remote Similarity NPD6535 Approved
0.6911 Remote Similarity NPD7501 Clinical (unspecified phase)
0.6889 Remote Similarity NPD7054 Approved
0.6883 Remote Similarity NPD1281 Approved
0.6879 Remote Similarity NPD1465 Phase 2
0.6871 Remote Similarity NPD3748 Approved
0.6871 Remote Similarity NPD4308 Phase 3
0.6868 Remote Similarity NPD6764 Approved
0.6868 Remote Similarity NPD6765 Approved
0.6867 Remote Similarity NPD6671 Approved
0.6862 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6862 Remote Similarity NPD6212 Phase 3
0.6862 Remote Similarity NPD6213 Phase 3
0.6859 Remote Similarity NPD8285 Discontinued
0.6853 Remote Similarity NPD7874 Approved
0.6853 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6852 Remote Similarity NPD6651 Approved
0.6851 Remote Similarity NPD7472 Approved
0.6846 Remote Similarity NPD1398 Phase 1
0.6839 Remote Similarity NPD6823 Phase 2
0.6832 Remote Similarity NPD4060 Phase 1
0.6829 Remote Similarity NPD4476 Approved
0.6829 Remote Similarity NPD4477 Approved
0.6824 Remote Similarity NPD5403 Approved
0.6821 Remote Similarity NPD9493 Approved
0.6821 Remote Similarity NPD7340 Approved
0.6818 Remote Similarity NPD7801 Approved
0.6818 Remote Similarity NPD7783 Phase 2
0.6818 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6815 Remote Similarity NPD2797 Approved
0.6813 Remote Similarity NPD6797 Phase 2
0.6813 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6811 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6806 Remote Similarity NPD7699 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data